| answer text |
<p>NHS England has recently announced plans to enable consistent national availability
of the Freestyle Libre Flash Glucose Monitoring device according to published guidance.</p><p>Clinical
commissioning groups (CCGs) can purchase any available blood glucose monitoring which
has been approved for sale on the open market. The availability of AccuChek Expert,
Dexcom G6 and Eversense XL products is a matter for CCGs who are primarily responsible
for commissioning diabetes services, to meet the requirements of their population.
In doing so, they need to ensure that the services they provide are fit for purpose,
reflect the needs of the local population, are based on the available evidence and
consider national guidelines. NHS England engages with technology companies developing
products that may be of significant benefit to those with diabetes to seek to increase
their availability to patients where appropriate.</p><p>The Department does not collate
data on the number of patients using these devices nationally or by clinical commissioning
group.</p>
|
|
